The report highlights the increasing prevalence of various types of cancer diseases that are driving the demand for chemotherapy infusion pumps. Consegic Business Intelligence study also provides insights into the market's competitive landscape, market segmentation, regional outlook, and emerging technologies in the chemotherapy infusion pumps market.
The chemotherapy infusion pumps market is bifurcated into type and end-users. Based on type, the market is segmented into large volume pumps, syringe pumps, ambulatory infusion pumps, elastomeric pumps, and others. In 2022, the syringe pump segment dominate in the overall chemotherapy infusion pumps market. The end-user segment is categorized into hospitals, clinics, home care, and others. In 2022, the hospital segment accounted for the highest market share in the chemotherapy infusion pumps market.Get Free Sample
|Report Attributes||Report Details|
|By Type||Large Volume Pumps, Syringe Pumps, Ambulatory Infusion Pumps, Elastomeric Pumps, and Others|
|By End-User||Hospitals, Clinics, Home Care, and Others|
|By Region||North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa|
The market is dominated by certain major companies such as BD, Micrel Medical Devices SA, and ICU Medical, Inc. have a strong market position in current market circumstances. Further, the chemotherapy infusion pumps market is expected to witness significant growth in the coming years due to the rising incidence of breast cancer that majorly involves chemotherapy treatment. The market players compete for a firm market position through mergers and acquisitions, product innovations, and business strategies. Thus, evolving research and developments are expected to help market players adopt innovative ways of product creation to cater to the growing needs of various end-use industries